Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

The Trump administration on Friday announced it would pull all federal education funding from Maine after state officials said they would not comply with demands from the administration to ban ...

Earlier, the company said it brought back dire wolves, which had been extinct for more than 12,000 years. It also has created ...

09:38 EDT Portage Biotech (PRTG) trading halted, volatility trading pause Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search ...

and a wonderful example of the power of biotechnology to protect species, both extant and extinct.” Drew Weisholtz is a reporter for TODAY Digital, focusing on pop culture, nostalgia and ...

The U.S. biotech sector had already been through a brutal few years before the latest market crash. Robert F. Kennedy Jr.’s shake-up of the nation’s health agencies and persistently high ...

Cell programming biotech bit.bio is slimming its workforce by 25% as the company pivots to focus on biomedical tools instead of therapeutics development. The decision was driven by “shifting ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

Every year, thousands of tonnes of brown algae are extracted from the seabed to obtain compounds such as alginates, a polymer composed of sugars that has high density and strength, offering ...

There remains much uncertainty about these measures, however. As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news.